Shire Email Format

Biotechnology Research
201-500 employees
Bedminster, NJ, USA

Shire is a biotechnology research company that developed treatments for rare diseases and specialty conditions before being acquired by Takeda Pharmaceutical in 2019.

Find contacts at Shire

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@shire.com

Company Overview

Industry
Biotechnology Research
Founded
1986
Headquarters
Bedminster, NJ, USA
Revenue
$25M-$50M
FUNDING Stage
Acquired
Key Executives
Julie Kim (CEO-Elect), Milano Furuta (Director - Chief Financial Officer)

Tech Stack

AWS

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Shire?

Shire uses the firstinitiallast format on shire.com, so Jane Smith would be jsmith@shire.com.

What therapeutic areas does Shire focus on in its rare disease portfolio?

Shire's rare disease portfolio spans immunology, hematology, and metabolic and lysosomal storage disorders. The company also maintains dedicated franchises in plasma-derived therapies, neuroscience, gastrointestinal diseases, and oncology.

How many people work at Shire?

Shire has approximately 146 employees and is headquartered in Bedminster, New Jersey. You can use a tool like Clay to build and verify a contact list of Shire staff for outreach purposes.

Who leads Shire's finance function?

Milano Furuta serves as Director and Chief Financial Officer at Shire. Julie Kim holds the CEO-Elect role. If you need to reach either executive, Clay can help you find and verify the right contact details.

What products is Shire known for in its neuroscience franchise?

Shire developed Vyvanse (lisdexamfetamine dimesylate) and Adderall XR, both used to treat ADHD, as core products within its neuroscience franchise. Vyvanse was also approved for binge eating disorder in adults in the United States.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles